ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0923

Influenza Virus Infection Alters the MHC Class II Self-Immunopeptidome to Present Lupus-Associated Autoantigens

Julia Rood1, Stephanie Suh Kyung Yoon2, Mary Heard1, Michael Hogan2, Nicola Ternette3, Edward Behrens4 and Laurence Eisenlohr1, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3University of Dundee, Dundee, Scotland, United Kingdom, 4CHOP, West Chester, PA

Meeting: ACR Convergence 2025

Keywords: autoantigens, immunology, Infection, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0916–0933) Innate Immunity Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Viral infections and major histocompatibility complex class II (MHC II) are both implicated in the genesis of systemic lupus erythematosus (SLE), but a mechanistic understanding of how these factors promote autoimmunity is lacking. One phenomenon observed for MHC class I-restricted self-peptides – but which remains largely unexplored for MHC II – is the ability of viruses to alter processing and presentation of endogenous self-antigens. We investigated the impact of infection with influenza, a virus associated with autoantibody formation in healthy individuals and disease flares in SLE patients, on the repertoire of self-peptides presented by MHC II.

Methods: A murine antigen presenting cell (APC) line expressing C57Bl/6-derived I-Ab, BALB/c-derived I-Ed, and class II transactivator-driven antigen processing and presentation components was either infected with the mouse-adapted H1N1 influenza strain PR8 or mock-infected in vitro. MHC II:peptide complexes were immunoprecipitated, and peptides were fractionated by reversed-phase high-performance liquid chromatography, analyzed by nano-ultra-performance liquid chromatography-tandem mass spectrometry, and identified from a database containing the influenza and mouse proteomes.

Results: An average of 9,895 peptides were identified among influenza-infected APCs per experimental replicate. Self-peptides comprised >95% of the MHC II immunopeptidome in influenza-infected cells, concordant with published observations from other intracellular pathogens. Among these self-peptides, 24-40% were unique to infected, rather than uninfected, cells. Functional annotation clustering revealed significant enrichment of ribosomal proteins and ribonucleoproteins (RNPs) among peptides unique to infected cells. Multiple unique epitopes were identified from ribosomal P0, a known target of anti-ribosomal P antibodies in SLE patients. We also identified peptides derived from histones, other nuclear DNA-binding proteins, and complement proteins including C3, an autoantibody target in at least one-third of SLE patients. Peptides derived from complement C3 were separately identified in published MHC II immunopeptidome data from H1N1 influenza-infected human cells.

Conclusion: Active influenza infection in vitro substantially alters the MHC II self-immunopeptidome and is associated with presentation of SLE autoantigens. These data suggest that influenza manipulates non-classical endogenous antigen processing pathways within APCs to expose new self-epitopes capable of activating autoreactive CD4+ T cells in SLE. Future studies will investigate intracellular processing of these peptides and their presentation in murine models of SLE to elucidate the mechanistic role of viral infection in promoting autoimmunity.


Disclosures: J. Rood: None; S. Yoon: None; M. Heard: None; M. Hogan: None; N. Ternette: None; E. Behrens: Ab2Bio, 5, Sobi, 2, 5, UpToDate, 9; L. Eisenlohr: None.

To cite this abstract in AMA style:

Rood J, Yoon S, Heard M, Hogan M, Ternette N, Behrens E, Eisenlohr L. Influenza Virus Infection Alters the MHC Class II Self-Immunopeptidome to Present Lupus-Associated Autoantigens [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/influenza-virus-infection-alters-the-mhc-class-ii-self-immunopeptidome-to-present-lupus-associated-autoantigens/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/influenza-virus-infection-alters-the-mhc-class-ii-self-immunopeptidome-to-present-lupus-associated-autoantigens/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology